Current Surgical is developing a smart needle designed to treat cancerous tumors

News Summary

  • Because we’re trying to change the paradigm in surgery, which will not fit into a 1-2 year time frame, we were excited to find our investors who had the same level of vision and ambition that we have.”
  • The round, which brings the firm’s total raise up to $4 million, was led by True Ventures and features 1517 Fund and SciFounders.
  • “Interestingly, this made it easier to identify investors (such as True Ventures) who are able to invest in long-term, high-potential projects, as they were not apprehensive about short-term uncertainty.
D.C.based Current Surgical this week announced a $3.2 million seed. The round, which brings the firms total raise up to $4 million, was led by True Ventures and features 1517 Fund and SciFounders. I [+2432 chars]